Skip to main content

Table 2 ECP and cytokine concentrations before and after treatment with montelukast.

From: Montelukast in the treatment of duodenal eosinophilia in children with dyspepsia: Effect on eosinophil density and activation in relation to pharmacokinetics

 

Pre-treatment

Post-treatment

ECP

10.6 ± 6.8

12.2 ± 9.0

IL-4

10.5 ± 5.7

11.7 ± 9.7

IL-5

1.8 ± 1.2

2.0 ± 2.1

IL-8

5.5 ± 7.8

8.5 ± 14.2

MCP-1

277.0 ± 199.7

289.3 ± 149

TNF-α

12.2 ± 15.3

10.2 ± 11.6

  1. *all differences non-significant
Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us